已收盤 09-20 16:00:00 美东时间
-0.050
-3.52%
Treatment with OTX-2002 led to controlled downregulation of MYC gene expression and resulted in significant inhibition of tumor growth as a monotherapy and in combination with standard of care agents in preclinical
09-17 19:13
Omega Therapeutics Announces Jennifer Nelson, Ph.d., as Senior Vice President o...
08-14 19:00
Omega Pacific Resources, Inc. (TSE:OMGA) has released an update. Omega Pacific ...
08-14 02:07
Top Wall Street analysts changed their outlook on these top names. For a comple...
08-07 20:26
Chardan Capital analyst Keay Nakae maintains Omega Therapeutics (NASDAQ:OMGA) with a Buy and lowers the price target from $7 to $6.
08-07 18:49
Omega Therapeutics Inc : Chardan Capital Markets Cuts Target Price to $6 From $7
08-07 12:07
Omega Therapeutics press release (NASDAQ:OMGA): Q2 GAAP EPS of -$0.30. Revenue of $2.13M. More on Omega Therapeutics Raymond James starts Omega at outperform, cites platform Seeking Alpha’s Quant Rati...
08-06 20:54
Omega Therapeutics Inc: As of June 30, Co Had Cash & Cash Equivalents of $4...
08-06 19:03
Omega Therapeutics Q2 Operating Expenses USD 18.714 Million
08-06 19:00
Omega Therapeutics Q2 Revenue USD 2.134 Million Vs. IBES Estimate USD 949 Thous...
08-06 19:00